Myriad Genetics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Myriad Genetics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11% to $753,200,000. Profit margin reached -35%. Total operating expenses were $774,400,000.

Profit Margin

Myriad Genetics, Inc. (NASDAQ:MYGN): Profit margin
2011 402.08M 100.71M 25.05%
2012 496.00M 112.15M 22.61%
2015 723.1M 80.2M 11.09%
2016 753.8M 125.3M 16.62%
2018 772.6M 131M 16.96%
2019 851.1M 4.6M 0.54%
2020 557M -223.7M -40.16%
2021 690.6M -27.2M -3.94%
2022 678.4M -112M -16.51%
2023 753.2M -263.3M -34.96%

MYGN Income Statement (2011 – 2023)

2023 2022 2021 2020 2018 2017 2015 2014 2012 2011
Revenue
Revenue
753.2M678.4M690.6M557M851.1M772.6M753.8M723.1M496.00M402.08M
Cost of revenue
236.2M202M197.6M178.2M201M177.2M157.3M147.4M64.65M46.71M
Gross profit
517M476.4M493M378.8M650.1M595.4M596.5M575.7M431.34M355.37M
Operating exp.
Research and development
88.7M85.4M81.9M80.9M85.9M70.8M70.6M75.5M42.64M27.75M
Selling and marketing
0000000000
Total operating expenses
774.4M600.1M681.7M653.3M641.4M537.9M429.7M441.5M251.02M197.59M
Operating income
-257.4M-123.7M-48.7M-194.8M7.6M118.7M166.8M134.2M180.31M157.77M
Other income (expenses), net
-4.8M-16.9M-8.4M-88.9M100K60.8M1.2M300K4.22M-1.87M
Income before tax
-262.2M-140.6M-57.1M-283.7M7.7M116.9M168.9M134.9M184.54M159.65M
Income tax expense
1.1M-28.6M-29.9M59.9M-4.4M-13.9M43.6M54.7M72.38M58.94M
Net income
-263.3M-112M-27.2M-223.7M4.6M131M125.3M80.2M112.15M100.71M
Earnings per share
Basic EPS
-3.18-1.39-0.35-2.990.061.891.791.121.331.12
Diluted EPS
-3.18-1.39-0.35-2.990.061.821.711.081.31.1
Data sourceData sourceData sourceData sourceData sourceData sourceData source